Researchers at the University of Seville performed a study to develop an easy strategy for accurately classifying hepatocellular carcinoma (HCC) risk in hepatitis C virus (HCV) patients with sustained virological response (SVR). The findings have been published in the American Journal of Gastroenterology. A 1,000-patient cohort was part of the study, which emphasizes the importance of individualized medication and evaluation of hepatitis C virus (HCV) patients, even after they have recovered from the illness.
Patients at risk were identified using a mixture of two diagnostic methods: transient elastography (TE) and ultrasound. Current guidelines call for follow-up after recovery based on baseline data (lab tests or transient elastography before starting treatment). However, this study suggests that changes after treatment should be taken into account for better risk stratification.…
